AeroVanc: Phase Ia data

Top-line data from 18 healthy volunteers in the Phase Ia portion of an open-label, vancomycin-controlled, Australian Phase Ia/Ib trial showed that single doses of 16, 32 and 80 mg AeroVanc were well t...